COPD

May 29, 2015November 9, 2015

FDA Approves Boehringer Ingelheim’s Stiolto Respimat as Maintenance Treatment for Patients With COPD

COPD, News

Boehringer Ingelheim announced that the FDA has approved once-daily Stiolto™ Respimat® (tiotropium bromide and olodaterol) Inhalation Spray. The drug was approved for long-term continuation therapy of the obstruction of the airflow in chronic ... Read more

May 28, 2015November 9, 2015

toSense Receives 510(k) Clearance For CoVa At-Home Patient Monitoring System For COPD, Other Diseases

COPD, News

La Jolla, California based toSense has received of 510(k) clearance from the Food and Drug Administration (FDA) for the company’s CoVa Monitoring System (CoVa), a novel body-worn sensor for at-home ... Read more

May 25, 2015November 9, 2015

Novartis Reveals Promising Results on Phase III Trials for Two Therapeutic Drugs against COPD

COPD, News

Novartis recently announced encouraging positive results on two of its pivotal Phase III clinical trial programs, the EXPEDITION program to assess the efficacy of QVA149 (indacaterol/glycopyrronium bromide) and the GEM program ... Read more

May 22, 2015November 9, 2015

Novartis Presents Results for Compound That Improves COPD Lung Function at ATS 2015

COPD, News

Novartis recently announced the results of the EXPEDITION trial, a phase III study that is evaluating the efficacy of QVA149 (indacaterol/glycopyrronium) in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD). ... Read more

May 21, 2015November 9, 2015

Poor, Rural US Regions Have Higher Prevalence of COPD

COPD, News

The prevalence of chronic obstructive pulmonary disease (COPD) is influenced by residency location and income, according to a research team led by Sarath Raju, MD, MPH, from the Johns Hopkins School of Medicine in ... Read more

May 21, 2015November 9, 2015

Boehringer’s Drug Combination Therapy For COPD Promotes Lung Function Improvement in Patients

COPD, News

Boehringer Ingelheim Pharmaceuticals, Inc. recently announced new data from the pivotal Phase III TONADO™ 1&2 studies (NCT01431274 and NCT01431287), regarding the efficacy and safety of its investigational product tiotropium/olodaterol delivered via ... Read more

May 20, 2015November 9, 2015

Predictors of Exacerbations Studied in Chronic Obstructive Pulmonary Disease

COPD, News

In a study recently presented during the 2015 American Thoracic Society International Conference , researchers from Brigham and Women’s Hospital in Boston found an association between exacerbations chronic obstructive pulmonary disease ... Read more

May 18, 2015November 9, 2015

Anemia Reduces Exercise Capacity, Negatively Impacts Quality of Life in COPD Patients

COPD, News

Findings from a recent study published in the journal BMC Pulmonary Medicine show that anemia reduces exercise capacity and negatively impacts quality of life in patients with COPD. Chronic obstructive ... Read more

May 18, 2015November 9, 2015

Patient Quality of Life Found To Be a Reliable Predictor of Medical Costs Related to COPD Care

COPD, News

A new study recently published in the journal Health and Quality of Life Outcomes revealed that in China, the quality of life of patients with chronic obstructive pulmonary disease (COPD) ... Read more

May 14, 2015November 9, 2015

Boehringer and Sutter Health Collaborate on COPD Patient Care

COPD, News

Boehringer Ingelheim and the not-for-profit network of hospitals, Sutter Health, established a five-year partnership focused on research and healthcare innovation, which will begin focusing on the treatment of chronic obstructive pulmonary disease (COPD). ... Read more